Journal
LEUKEMIA RESEARCH
Volume 34, Issue 6, Pages 714-717Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2009.08.005
Keywords
Chronic myeloid leukemia; Pharmacokinetics; Therapeutic drug monitoring; HPLC; LCMSMS
Categories
Ask authors/readers for more resources
The aims of this study were to validate and compare HPLC and LCMSMS analytical methods and their applicability for the quantitation of imatinib in human plasma. A total of 50 patients with chronic myeloid leukemia (CML) in chronic phase (CP) receiving 400 mg/day imatinib were enrolled in the study. Drug levels were determined by HPLC-UV and LCMSMS. HPLC intra-day accuracy ranged from 100.51 to 103.19%. LCMSMS accuracy ranged from 89.72 to 106.29%. The correlation coefficient between both methods was r(2) = 0.96. HPLC can be used for imatinib levels' determinations in patients accurately and precisely. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available